“Facts Over Special Interests“
A comprehensive body of independent research from Harvard, JAMA, the British Medical Journal, the American Enterprise Institute, and other leading institutions — all pointing to the same conclusion: physician-led hospitals deliver higher-quality care, lower costs, and greater efficiency.
A Ban Based on Politics, Not Evidence
In 2010, the Affordable Care Act imposed an arbitrary ban on physician-led hospitals — not to improve healthcare, but to eliminate competition at the behest of special interest lobbyists. Tucked away as Section 6001, the provision prohibited new physician-led hospitals from opening and severely restricted grandfathered hospitals from expanding.
Accelerated Consolidation
Hospital consolidation has increased dramatically, resulting in higher prices and decreased patient options across every market.
Fewer Patient Choices
Patients have lost access to competitive alternatives, leaving many communities with fewer options for high-quality, affordable care.
Soaring Healthcare Costs
With competition stifled, healthcare costs have continued to climb for both patients and public payers like Medicare.
Diminished Access
Patient access to high-quality, low-cost care has diminished — especially in underserved and rural communities.
The Numbers Don’t Lie
Decades of independent research consistently demonstrate that physician-led hospitals increase market competition, lower costs, and raise the bar on quality of care.
What the Research Shows
Studies from leading institutions consistently find physician-led hospitals outperform across every major category.
Quality of Care
- Match or exceed non-POHs on mortality and readmission rates
- Patient experience score 3.9 vs. 3.2 for all hospitals
- 41% receive highest patient rating vs. only 6% of all hospitals
- Shorter lengths of stay without increased complications
Cost & Pricing
- 59% of POHs have lower Medicare costs than national median
- Commercial prices 17.5–33.7% lower than non-POHs
- Cash prices 32.7–46.7% lower than non-POHs
- $217 million in Medicare savings (2019)
Access & Equity
- Identical Medicare patient proportions (47.1% vs. 47.2%)
- Similar Medicaid patient proportions (14.9% vs. 15.4%)
- Comparable minority patient populations
- No evidence of systematic cherry-picking
Market Competition
- 16.7% lower concentration scores in POH markets
- Only 4% of POH markets “very highly concentrated” vs. 13%
- POHs represent only 6.3% of market share — not a threat
- Critical counterpoint to consolidation trends
Economic Impact
- $43.1 billion in total economic output
- $10.3 billion in wages supported
- $1.25 billion in taxes paid
- $546 million in total uncompensated care
Innovation & Flexibility
- Physician-led governance enables rapid innovation
- COVID: 102-bed hospital converted in just 10 days
- Counterweight to hospital labor monopsony power
- Ownership model improves recruiting and retention
Studies from Leading Institutions
These studies directly challenge the outdated political arguments used to justify the 2010 ban — showing instead that physician-led hospitals serve diverse patient populations while delivering measurable value.
Key Findings
- 186 POHs analyzed across 92 hospital referral regions vs. 1,230 non-POHs
- For all 20 high-cost DRGs, POHs delivered care at 8–15% lower Medicare payment rates
- Per-episode savings ranged from $726 to $5,925
- If all cases treated in POHs, Medicare could have saved approximately $1.1 billion in 2019
Patient Demographics
Patient demographics and comorbidities were statistically similar between hospital types — no evidence of “cherry-picking.” Cost differences persisted after adjusting for patient characteristics.
Pricing Findings
- 156 POHs and 1,116 non-POHs across 78 hospital referral regions
- POHs had 4–33% lower commercial negotiated prices for 7 of 8 services
- Hospital-plan level: POH status associated with 17.5% lower negotiated prices
- POH status associated with 46.7% lower cash prices
Procedures Analyzed
Eight CMS-designated shoppable services including spinal injection, MRI scans, CT scans, comprehensive metabolic panel, blood clotting tests, and emergency department visits.
Demographics — No Cherry-Picking
- 219 POHs and 1,967 non-POHs across 95 hospital referral regions
- Medicare patients: 47.1% vs. 47.2% (p=0.97)
- Medicaid patients: 14.9% vs. 15.4% (p=0.75)
- Equivalent 30-day mortality rates (13.9% vs. 13.9%, p=0.91)
Key Conclusion
POHs held only 6.3% of Medicare admissions in their markets — minimal impact on competing hospitals’ financial viability. General POHs served greater proportions of Medicaid patients (18.4%) than specialty POHs (7.6%).
Market Consolidation Crisis
- Analysis of 1,412 hospital mergers between 1998–2015
- Consolidation drives increased prices, decreased options, and lesser patient experience
- POH growth before 2010 was a rare counterpoint to consolidation trends
Recommendation
Authors (FTC and DOJ staff) recommend Congress should consider removing the POH ban. The ban was not related to main ACA provisions — it was the result of legislative horse-trading. Industry groups freely admitted their lobbying success.
Economic Impact (2021)
- 166,365 total jobs supported (72,512 direct + 93,853 indirect/induced)
- $10.3 billion in wages · $43.1 billion in economic output
- $1.25 billion in federal and state taxes
- $240.1 million in charity care · $546.2 million in total uncompensated care
Market Competition
- Markets with POHs have 16.7% lower concentration scores (2,776 vs. 3,334)
- 59% of POHs have lower Medicare costs per beneficiary than national median
- Average savings of $1,500 per Medicare patient
Cost Findings
- Hospital-owned practices had 5.8% higher annual spending ($280 more per patient)
- 13% higher imaging costs · 21.4% higher unclassified services spending
- 47.9% vs. 39.1% paid outpatient facility fees
- Higher costs driven by utilization, not prices
Policy Implication
“Financial integration between physicians and hospitals raises patient spending but not care quality.” No consistent difference in quality; no difference in 30-day readmissions.
Let the Evidence Speak
The research is clear. It’s time to repeal the arbitrary ban and let physician-led hospitals compete on a level playing field.
Download the Full Report (PDF)